<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Prod Bioprospect</journal-id><journal-id journal-id-type="iso-abbrev">Nat Prod Bioprospect</journal-id><journal-title-group><journal-title>Natural Products and Bioprospecting</journal-title></journal-title-group><issn pub-type="ppub">2192-2195</issn><issn pub-type="epub">2192-2209</issn><publisher><publisher-name>Springer Singapore</publisher-name><publisher-loc>Singapore</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7520468</article-id><article-id pub-id-type="publisher-id">259</article-id><article-id pub-id-type="doi">10.1007/s13659-020-00259-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title><italic>Salvia ceratophylla</italic> L. from South of Jordan: new insights on chemical composition and biological activities</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Abu-Darwish</surname><given-names>Mohammad Sanad</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cabral</surname><given-names>C&#x000e9;lia</given-names></name><address><email>celia.cabral@fmed.uc.pt</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ali</surname><given-names>Zulfigar</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Shabana I.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Jacob</surname><given-names>Melissa R.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>Surendra K.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Tekwani</surname><given-names>Babu L.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zulfiqar</surname><given-names>Fazila</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Ikhlas A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Taifour</surname><given-names>Hatem</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Salgueiro</surname><given-names>L&#x000ed;gia</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Efferth</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.443749.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0623 1491</institution-id><institution>Department of Basic and Applied Sciences, </institution><institution>Al-Balqa Applied University, </institution></institution-wrap>Al-Salt, 19117 Jordan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.251313.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2169 2489</institution-id><institution>National Center for Natural Products Research, School of Pharmacy, </institution><institution>University of Mississippi, </institution></institution-wrap>University, MS 38677 USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution>Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, </institution><institution>University of Coimbra, </institution></institution-wrap>3000-548 Coimbra, Portugal </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution>Center for Innovative Biomedicine and Biotechnology (CIBB), </institution><institution>University of Coimbra, </institution></institution-wrap>3000-548 Coimbra, Portugal </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution>Centre for Functional Ecology, Department of Life Sciences, </institution><institution>University of Coimbra, </institution></institution-wrap>Cal&#x000e7;ada Martim de Freitas, 3000-456 Coimbra, Portugal </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.4305.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7988</institution-id><institution>School of Geosciences, </institution><institution>University of Edinburgh, </institution></institution-wrap>219 Crew Building, King&#x02019;s Buildings, Edinburgh, EH9 3FF UK </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution>CIEPQPF/Faculty of Pharmacy, </institution><institution>University of Coimbra, </institution></institution-wrap>Health Sciences Campus, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.5802.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 1941 7111</institution-id><institution>Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biocmedical Sciences, </institution><institution>Johannes Gutenberg University, </institution></institution-wrap>Staudinger Weg 5, 55128 Mainz, Germany </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><volume>10</volume><issue>5</issue><fpage>307</fpage><lpage>316</lpage><history><date date-type="received"><day>29</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>1</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">In Jordan, <italic>Salvia ceratophylla</italic> L. is traditionally used in the treatment of cancer, microbial infections, and urinary disorders. This study aimed: (1) to chemically characterize <italic>S. ceratophylla</italic> essential oil (EO) from South Jordan, by gas chromatography (GC) and gas chromatography-mass spectrometry (GC&#x02013;MS); and (2) to evaluate in vitro the cytotoxic, anti-inflammatory, and antiprotozoal activities of the EO, it&#x02019;s predominant components, and the hexane (A), ethyl acetate (B), methanol (C) and crude-methanol extracts (D). The analysis revealed that the EO has 71 compounds, with linalool (54.8%) as main constituent. Only the hexane extract (A) showed some cytotoxic activity against SK-MEL, KB, BT-549, SK-OV-3, LLC-PK1 and VERO cells lines with IC<sub>50</sub> between 60 and&#x02009;&#x0003e;&#x02009;100&#x000a0;&#x000b5;g/mL. The EO inhibited NO production (IC<sub>50</sub> 90&#x000a0;&#x000b5;g/mL) and NF-&#x003ba;B activity (IC<sub>50</sub> 38&#x000a0;&#x000b5;g/mL). The extracts A, B, and D inhibited NO production and NF- &#x003ba;B activity with IC<sub>50</sub> between 32 and 150&#x000a0;&#x000b5;g/mL. Linalool considerably inhibited NO production (IC<sub>50</sub> 18&#x000a0;&#x000b5;g/mL). The extracts tested did not exhibit antileishmanial activity. Regarding antitrypanosomal activity, the EO exhibited significant results with IC<sub>50</sub> 2.65&#x000a0;&#x000b5;g/mL. In conclusion, Jordan <italic>S. ceratophylla</italic> EO represents a rich source of linalool and bears a promising therapeutic potential for further antitrypanosomal drug development.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Lamiaceae</kwd><kwd>Essential oil</kwd><kwd>Chemical composition</kwd><kwd>Cytotoxicity</kwd><kwd>Anti-inflammatory activity</kwd><kwd>Neglected diseases</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000592</institution-id><institution>US-UK Fulbright Commission</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005672</institution-id><institution>Funda&#x000e7;&#x000e3;o de Apoio ao Desenvolvimento do Ensino, Ci&#x000ea;ncia e Tecnologia do Estado de Mato Grosso do Sul</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2"><italic>Salvia ceratophylla</italic> L. (Arabic: <italic>Lusan Al-haea</italic>, English: horn-leaved sage) is a biennial lemon-scented herb and one of the 19 indigenous <italic>Salvia</italic> species native in Jordan [<xref ref-type="bibr" rid="CR1">1</xref>]. This species grows in diverse Jordanian geographic areas, such as Mafraq, Ajlun, Ma'an, Tafila and Dana [<xref ref-type="bibr" rid="CR1">1</xref>] and Wadi Musa [<xref ref-type="bibr" rid="CR2">2</xref>]. It is also found in several Asian-temperate regions, including Caucasus, Transcaucasus, Middle Asia (Turkmenistan), and Near East <bold>(</bold>Afghanistan, Iran, Iraq, Lebanon, Syria, Palestine, Israel, and Turkey) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par3"><italic>S. ceratophylla</italic> is used in traditional medicine of the Middle East against various ailments, e.g<italic>.</italic> inflammation, fungal, and nociceptive diseases [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. In Middle Eastern countries such as Jordan, Lebanon, and Syria, the herbalists prescribe <italic>Salvia</italic> species as boiled tea to relieve abdominal pain, headaches, stomachaches, and to treat cancer, microbial infections, asthma, coughs and other pulmonary and urinary disorders [<xref ref-type="bibr" rid="CR7">7</xref>]. It is also recommended in folk medicine to disinfect homes after sickness [<xref ref-type="bibr" rid="CR8">8</xref>]. Several <italic>Salvia</italic> species and their essential oils are used in various traditional medicines to treat malaria [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] and leishmaniasis [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par4">Despite the composition of <italic>S. ceratophylla</italic> essential oil (EO) grown in various habitats of the Near East countries has been analyzed and a wide variation in their composition has been reported [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>], there is only one report on the composition of <italic>S. ceratophylla</italic> EO originated from the middle of Jordan [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par5">Few reports showed the biological activities of <italic>S. ceratophylla</italic> extracts from various locations in the Middle East. Some <italic>S. ceratophylla</italic> extracts revealed cytotoxic activity against some types of cancer cell lines [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par6">The antioxidant activity of <italic>S. ceratophylla</italic> originated from Turkey and Iran has been assessed by different methods. G&#x000fc;rsoy et al. [<xref ref-type="bibr" rid="CR3">3</xref>] showed the antioxidant activity of essential oil of <italic>S. palaestina</italic> and <italic>S. ceratophylla</italic> from Turkey. The <italic>S. ceratophylla</italic> chloroform extract inhibited the activity of butyrylcholine esterase [<xref ref-type="bibr" rid="CR18">18</xref>]. Among 9 <italic>Salvia</italic> species from Iran, the methanolic extract of <italic>S. glutinosa</italic> and <italic>S. ceratophylla</italic> revealed the strongest antioxidant activity [<xref ref-type="bibr" rid="CR17">17</xref>]. The anti-inflammatory activity of the EO from <italic>Salvia</italic> species is mediated by the inhibition of nitric oxide (NO) production and nuclear kappa B (NF-&#x003ba;B) activation [<xref ref-type="bibr" rid="CR10">10</xref>]. Linalool and linalyl acetate, the major volatile constituents of the EO of several aromatic plants exhibit in vivo strong anti-inflammatory activity against Carrageenin-induced edema [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par7">The extracts and EO of some other <italic>Salvia</italic> species showed antiprotozoal activity against malaria, leishmaniasis and human African trypanosomiasis [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>]. The hydroalcoholic extract of <italic>S. officinalis</italic> from Algeria completely inhibited the growth of <italic>Leishmania major</italic> [<xref ref-type="bibr" rid="CR23">23</xref>]. Furthermore, linalool exhibited antileishmanial activity in a concentration-dependent fashion [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Caryophyllene showed anti-protozoal activity against <italic>Leishmania donovani</italic> [<xref ref-type="bibr" rid="CR26">26</xref>] and <italic>Trypanosoma brucei</italic> [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par8">Only a few studies reported the biological activities of <italic>S. ceratophylla</italic> from Jordan. However, the anti-inflammatory activity of hexane, ethyl acetate and methanol extracts obtained from the aerial parts of Jordanian <italic>Salvia</italic> species have been evaluated by inhibition of croton oil-induced mouse ear edema [<xref ref-type="bibr" rid="CR6">6</xref>]. Kasabri et al. [<xref ref-type="bibr" rid="CR5">5</xref>] studied the inhibitory activity of the aqueous extracts of <italic>S. ceratophylla</italic> and other <italic>Salvia</italic> species grown in Jordan against pancreatic triacylglycerol lipase, &#x003b1;-amylase and &#x003b1;-glucosidase. <italic>S. ceratophylla</italic> exhibited cytotoxic efficacy against CaCo2 cells with an IC<sub>50</sub> value of 9.2&#x02009;&#x000b1;&#x02009;0.5&#x000a0;&#x003bc;g/mL.</p><p id="Par9">However, there is limited information about the chemical composition and biological activities of medicinal plants from Jordan flora. No studies have been carried out yet on <italic>S. ceratophylla</italic> EO from Dana Biosphere Reserve in southern Jordan and to the best of our knowledge, there are no previous reports on the antiprotozoal activity of this plant. Thus, the aim of this work was to evaluate for the first time the chemical composition of <italic>S. ceratophylla</italic> EO grown in Dana Biosphere Reserve (Southern Jordan), as well as, to assess the cytotoxic, antileishmanial, and antimalarial activities of its essential oil and other extracts.</p></sec><sec id="Sec2"><title>Materials and Methods</title><sec id="Sec3"><title>Plant Material</title><p id="Par10">Aerial parts of <italic>S. ceratophylla</italic> were collect during the spring season, throughout Dana Biosphere Reserve (South of Jordan). The voucher specimens were identified by Mr. Hatem Taifour (Researcher at School of GeoSciences, University of Edinburgh Edinburgh EH9 3FF, U.K.) and were deposited in the Herbarium of Shoubak University College, Al-Balqa Applied University, Jordan under the number #0009- Sc-DSh-2015 and in the Herbarium of National Center for Natural Products Research, School of Pharmacy, University of Mississippi, USA under the number #18,330. The plant material for extraction was air dried and crushed into small pieces with a hammer mill before extraction.</p></sec><sec id="Sec4"><title>Isolation of Extracts</title><sec id="Sec5"><title>Isolation of Essential Oil</title><p id="Par11">To isolate EO, the crushed aerial parts of <italic>S. ceratophylla</italic> were hydro distillated during 3&#x000a0;h with a Clevenger-type apparatus, according to the European Pharmacopoeia [<xref ref-type="bibr" rid="CR28">28</xref>]. The oil obtained was dried over anhydrous sodium sulphate and kept at 4 &#x000ba;C until analyzed and tested.</p></sec><sec id="Sec6"><title>Extraction of Non-polar and Polar Extracts</title><p id="Par12">The hexane, ethyl acetate, and methanol extracts from the crude areal parts of <italic>S. ceratophylla</italic> were obtain as follows: powdered plant material (600&#x000a0;g) was soaked with hexane followed by ethyl acetate, and then methanol for 48&#x000a0;h for each solvent in ratio of 500&#x000a0;mL per 100&#x000a0;g. The process of extraction for each solvent was repeat several times to ensure complete extraction of the compounds. The obtained extracts for each solvent were combine together and subject to rotary evaporation at 40&#x000a0;&#x000b0;C. The evaporation led to dry hexane (A), ethyl acetate (B), and methanol (C) extracts with yields of 4.21%, 1.77% and 6.93%, respectively.</p></sec><sec id="Sec7"><title>Extraction of Crude Methanol Extract</title><p id="Par13">A sample of 50&#x000a0;g of powder plant materials was soaked in 250&#x000a0;mL of methanol for 48&#x000a0;h. The process of extraction was repeat several times to ensure complete extraction of the compounds. The obtained methanol extracts were filter combined and subject to rotary evaporation at 40&#x000a0;&#x000b0;C. The obtained crude methanol dry extract (D) yielded 18.96%. All extracts (A-D) were freeze-dry and stored at 4&#x000a0;&#x000b0;C for further analyses.</p></sec></sec><sec id="Sec8"><title>Chemical Composition</title><sec id="Sec9"><title>Chemicals</title><p id="Par14">GC-grade n-hexane (&#x0003e;&#x02009;99%) and the reference standards were purchased from Sigma-Aldrich or isolated in the National Center for Natural Products Research, University of Mississippi. A mixture of n-alkanes (C<sub>8</sub>H<sub>18</sub>&#x02013;C<sub>23</sub>H<sub>48</sub>) was use in the determination of retention indices and were purchased from PolyScience Corp.</p></sec><sec id="Sec10"><title>Gas Chromatography-Mass Spectrometry (GC&#x02013;MS)</title><p id="Par15">Gas chromatography analysis was performed in an Agilent 7890B GC equipped with a 5975C quadruple mass spectrometer and a 7693-auto sampler. Separation was achieve using an Agilent J&#x00026;W HP-1 (100% dimethyl-polysiloxane) fused silica capillary column (60&#x000a0;m&#x02009;&#x000d7;&#x02009;0.25&#x000a0;mm I.D.&#x02009;&#x000d7;&#x02009;0.25&#x000a0;&#x000b5;M film thickness). Helium was the carrier gas at a constant flow rate of 1.5&#x000a0;mL/min. Oven temperature program: 50&#x000a0;&#x000b0;C hold for 2&#x000a0;min, after 50&#x02013;170&#x000a0;&#x000b0;C at 2&#x000a0;&#x000b0;C/min, 170&#x02013;250&#x000a0;&#x000b0;C at 6&#x000a0;&#x000b0;C/min (hold 10&#x000a0;min). The injector temperature was 250&#x000a0;&#x000b0;C, the injection volume was 0.5 &#x000b5;L and a split ratio of 50:1. The EO was diluted in n-hexane (0.5% v/v) prior to GC/MS analysis.</p><p id="Par16">Mass spectra were record at 70&#x000a0;eV at a scan mode from m/z 40 to 500. The transfer line and the ion source temperatures were 260&#x000a0;&#x000b0;C and 230&#x000a0;&#x000b0;C, respectively. Data acquisition was made with Agilent MSD Chemstation (F.01.03.2357).</p></sec><sec id="Sec11"><title>Identification of Individual Components</title><p id="Par17">Compound identification was carried out through comparison of the spectra with the database (Wiley and NIST) using a probability-based matching algorithm. Further identification was based on the relative retention indices compared with reference standards and literature data [<xref ref-type="bibr" rid="CR29">29</xref>].</p></sec></sec><sec id="Sec12"><title>Cytotoxic activity</title><p id="Par18">All cell lines used in this study were purchase from American Type Culture Collection (ATCC, Rockville, MD). The cytotoxic activity of the EO, extracts isolated from <italic>S. ceratophylla</italic> and pure compounds was determined in vitro against various human cancer cells: skin malignant melanoma (SK-MEL), human KB carcinoma (KB), breast ductal carcinoma (BT-549), ovarian carcinoma (SK-OV-3), and in two non-cancerous mammalian kidney cell lines (LLC-PK1 and VERO).</p><p id="Par19">Cells were seed at a density of 25,000 cells/well and incubated during 24&#x000a0;h. The tested EO, extracts and pure compounds were added separately at studied concentrations and cells were re-incubated during 48&#x000a0;h. After incubation time, the viability of cells was assessed by using Neutral Red Dye as described [<xref ref-type="bibr" rid="CR30">30</xref>]. DMSO was use as negative control and doxorubicin as positive control.</p></sec><sec id="Sec13"><title>Anti-inflammatory Activity</title><sec id="Sec14"><title>Inhibition of Cellular Oxidative Stress Assay</title><p id="Par20">The cellular antioxidant activity of <italic>S. ceratophylla</italic> EO and other extracts was measured in human HepG2 hepatoma cells This assay determines the ability of test samples to prevent intracellular generation of peroxyl radicals in response to 2,2- azobis (2-amidinopropane) dihydrochloride (ABAP, Sigma-Aldrich, St Louis, MO, USA).</p><p id="Par21">HepG2 cells were culture in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 50 units/mL penicillin and 50&#x000a0;&#x000b5;g/mL streptomycin. Cells were seed in 96-well plates (60,000 cells/well) and incubated for 24&#x000a0;h. The tested samples were diluted in serum free medium containing 25&#x000a0;&#x000b5;M 2<sup>&#x02032;</sup>,7&#x02032;, dichoroflouresceine diacetate (DCFH-DA, Invitrogen, Carlsbad, CA, USA). The cells were wash with PBS and treated with test samples during 1&#x000a0;h. The medium containing tested samples was removed, ABAP (600&#x000a0;&#x000b5;M) was added and the plate was immediately placed on a Spectra Max plate reader for kinetic reading every 5&#x000a0;min during 1&#x000a0;h (37 &#x000ba;C, emission at 538&#x000a0;nm and excitation at 485&#x000a0;nm). Quercetin (Sigma-Aldrich) was use as positive control. To calculate the percentage of decrease in oxidative stress, the Area Under the Curve (AUC) of fluorescence versus&#x000a0;time was used.<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Decrease in oxidative stress }}\left( \% \right) \, ={{\text{AUC control}}}^{{{1}00 - \, [{\text{AUC tested sample}} \times { 1}00]}} \,$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mrow><mml:mtext>Decrease in oxidative stress</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mfenced close=")" open="("><mml:mo>%</mml:mo></mml:mfenced><mml:mspace width="0.166667em"/><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mtext>AUC control</mml:mtext></mml:mrow></mml:mrow><mml:mrow><mml:mn>100</mml:mn><mml:mo>-</mml:mo><mml:mspace width="0.166667em"/><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mtext>AUC tested sample</mml:mtext></mml:mrow><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:msup><mml:mspace width="0.166667em"/></mml:mrow></mml:math><graphic xlink:href="13659_2020_259_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p></sec><sec id="Sec15"><title>Nitric Oxide (NO) Measurement</title><p id="Par22">The NO inhibition by EO, extracts of <italic>S. ceratophylla</italic> and pure compounds, was assess by the following methodology [<xref ref-type="bibr" rid="CR31">31</xref>]. Briefly, mouse macrophage cells (RAW 264.7) were culture in phenol red free RPMI medium with 10% bovine calf serum and 100 U/mL penicillin and 100&#x000a0;&#x000b5;g/mL streptomycin.</p><p id="Par23">Cells were seed in 96-well plates (50,000 cells/well) and incubated during 24&#x000a0;h. The tested samples were dilute in serum free medium, incubated during 30&#x000a0;min, then lipopolysaccharide (LPS, 5&#x000a0;&#x000b5;g/mL) was added and cells were incubated for further 24&#x000a0;h. The level of nitrite in the cell supernatant was measure by using Griess reagent. The inhibition of nitrite production by the tested samples was calculate in comparison to the vehicle control. Parthenolide (Sigma-Aldrich) was use as positive control. IC<sub>50</sub> values were obtain from dose curves.</p></sec><sec id="Sec16"><title>Assay for Inhibition of NF-&#x003ba;B Activity</title><p id="Par24">The inhibition activity of tested samples against NF-&#x003ba;B was evaluate as described [<xref ref-type="bibr" rid="CR31">31</xref>]. The SW 1353 human chondrosarcoma cell line was culture in a mixture of Dulbecco's Modified Eagle's Medium (DMEM) and Ham's F-12 Nutrient <bold>(</bold>DMEM/F12<bold>)</bold> supplemented with 10% FBS, 100 U/Ml penicillin and 100&#x000a0;&#x000b5;g/mL streptomycin. Cultured cells were washed in antibiotic and FBS-free DMEM/F12 medium and then re-suspended in FBS-free DMEM/F12 medium containing 2.5% FBS. NF-&#x003ba;B luciferase plasmid construct was added to the cell suspension in a concentration of 50&#x000a0;&#x000b5;g/mL and incubated for 5&#x000a0;min at 25&#x000ba;C. The cells were transfected by electroporation at 160&#x000a0;V and one 70&#x000a0;ms pulse using BTX disposable cuvettes (model 640 in a BTX Electro Square Porator T 820&#x02014;BTX I, San Diego, CA, USA), Transfected cells were plate in 96-well plates at a density of 1.25&#x02009;&#x000d7;&#x02009;10<sup>5</sup>cells per well in 200 &#x000b5;L of DMEM/F12 containing 10% FBS and antibiotics. After incubation for 24&#x000a0;h, the cells were treated with test samples for 30&#x000a0;min and then induced with PMA (70&#x000a0;ng/mL) for 8&#x000a0;h. The inhibition of NF-&#x003ba;B activity by EO, other extracts, and pure compounds was calculated in comparison to vehicle control. The IC<sub>50</sub> values were obtain from the dose curves. Parthenolide was use as positive control.</p></sec></sec><sec id="Sec17"><title>Antileishmanial and Antitrypanosomal Activities</title><sec id="Sec18"><title>Sample Preparation</title><p id="Par25">EO and extracts (A-D) at a stock concentration of 20&#x000a0;mg/mL were dilute to 4&#x000a0;mg/mL with DMSO. The obtained solutions (4&#x000a0;mg/mL) were four-fold diluted with incomplete RPMI medium to 1&#x000a0;mg/mL. Pure compounds at a stock concentration of 2&#x000a0;mg/mL in DMSO were diluted four-fold with incomplete RPMI medium to 0.5&#x000a0;mg/mL.</p></sec><sec id="Sec19"><title>In Vitro Antileishmanial and Antitrypanosomal Assays</title><p id="Par26">The extracts and pure compounds (highest concentrations 20&#x000a0;&#x000b5;g/mL for extracts and 10&#x000a0;&#x000b5;g/mL for pure compounds) were subject to different tests, namely <italic>Leishmania donovani</italic> promastigote assay, <italic>L. donovani</italic> axenic amastigote assay<italic>, L. donovani</italic> THP1 macrophage amastigote assay<italic>, Trypanosoma brucei</italic> trypamastigotes assay and THP1 toxicity assay. Alamar Blue assay was perform as previously described by other authors [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par27">These assays have been adapted to 384-well micro-plate format. A 3&#x02013;4&#x000a0;days old culture of <italic>Leishmania donovani</italic> promastigotes harvested in the exponential growth phase was diluted with RPMI medium to 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/mL for promastigote assays. A 3&#x02013;4&#x000a0;days old culture of <italic>Leishmania donovani</italic> axenic amastigotes was diluted with RPMI medium to 2&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/mL for axenic amastigote assays. A 2&#x000a0;days old culture of <italic>Trypanosoma brucei</italic> harvested in the exponential phase was diluted with Iscove's Modified Dulbecco's Medium (IMDM) to 5&#x02009;&#x000d7;&#x02009;10<sup>3</sup> cells/mL for the antitrypanosomal assay.</p><p id="Par28">Samples were added to the <italic>L. donovani</italic> promastigotes, <italic>L. donovani</italic> axenic amastigotes or <italic>T. brucei</italic> trypamastigotes cultures. The extracts were initially test at single concentrations of 20&#x000a0;mg/mL for primary screening. The active extracts and pure compounds were test at three or six concentrations ranging from 10 to 0.0032&#x000a0;&#x000b5;g/mL. The plates were incubated at 26&#x000a0;&#x000b0;C for 72&#x000a0;h (37&#x000a0;&#x000b0;C for axenic amastigotes and <italic>T. brucei</italic> trypamastigotes) and growth of cultured parasites was determined by the Alamar Blue assay [32 33].</p><p id="Par29">The extracts and single compounds were also test against <italic>L. donovani</italic> intracellular amastigotes in THP1 cells employing a recently developed parasite-rescue and transformation assay [<xref ref-type="bibr" rid="CR15">15</xref>].</p></sec></sec><sec id="Sec20"><title>THP1 Toxicity Assay and Macrophage Amastigote Assay</title><p id="Par30">A 4&#x000a0;days old THP1 cell culture harvested in the exponential growth phase was diluted with RPMI medium to 2.5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL. PMA was added to a final concentration of 25&#x000a0;ng/mL. A PMA treated culture was dispense in experimental culture plates and incubated overnight at 37&#x000a0;&#x000b0;C in a 5% CO<sub>2</sub> incubator. The plates with differentiated THP1 cells were wash with serum-free medium. For THP1 toxicity assay, the diluted test samples (extracts or pure compounds) were add over differentiated THP1 cells and plates were incubated during 48&#x000a0;h at 37&#x000a0;&#x000b0;C in a 5% CO<sub>2</sub> incubator. Cell growth was determined by the Alamar Blue assay. IC<sub>50</sub> and IC<sub>90</sub> values were calculate from dose response curves using XLFit&#x000ae; [<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec></sec><sec id="Sec21"><title>Results and Discussion</title><sec id="Sec22"><title>Essential Oil Composition</title><p id="Par31">In this study, the yield (0.34&#x02009;&#x000b1;&#x02009;0.001%) of <italic>S. ceratophylla</italic> EO was higher than in other studies performed in the middle of Jordan, where the yield was 0.1% [<xref ref-type="bibr" rid="CR15">15</xref>]. It is also lower than those grown in Turkey with a yield of 0.4% [<xref ref-type="bibr" rid="CR13">13</xref>] and 0.8% [<xref ref-type="bibr" rid="CR3">3</xref>] and in Iran (0.6%, [<xref ref-type="bibr" rid="CR12">12</xref>]). Usually, the yield variation of <italic>S. ceratophylla</italic> EO is relate to the influence of environmental factors linked to predominant climatic and geographical differences in various growth areas [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par32">The EO was analyzed by GC and GC/MS, the identified components and their relative percentages are listed in Table <xref rid="Tab1" ref-type="table">1</xref>. Seventy-one components were identified, representing 93.5% of the total constituents (Table <xref rid="Tab1" ref-type="table">1</xref>). The major compounds of the EO were linalool (54.8%), germacrene-D (6.4%), bicyclogermacrene (5%) and the bicyclic diterpene alcoholsclareol (4.3%). As far as we know, there is no previous report on the <italic>S. ceratophylla</italic> EO composition originated from Dana Biosphere Reserve (Southern Jordan). However, there are some works reporting the chemical composition of <italic>S. ceratophylla</italic> originated from middle of Jordan [<xref ref-type="bibr" rid="CR15">15</xref>], Turkey [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>] and Iran [<xref ref-type="bibr" rid="CR12">12</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Composition of <italic>Salvia ceratophylla</italic> L<italic>.</italic> essential oil from Dana Biosphere Reserve, South Jordan</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">No.</th><th align="left">RRI</th><th align="left">Compounds</th><th align="left">%</th></tr></thead><tbody><tr><td align="left"/><td align="left">969</td><td align="left">&#x003b2;-Pinene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">981</td><td align="left">&#x003b2;-Myrcene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1010</td><td align="left">1,8-Cineole</td><td char="." align="char">2.0</td></tr><tr><td align="left"/><td align="left">1019</td><td align="left"><italic>trans</italic>-Ocimene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1029</td><td align="left"><italic>cis</italic>-Ocimene</td><td char="." align="char">0.4</td></tr><tr><td align="left"/><td align="left">1038</td><td align="left">&#x003b3;-Terpinene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1045</td><td align="left"><italic>trans</italic>-Linalool oxide</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1058</td><td align="left"><italic>cis</italic>-Linalool oxide</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1074</td><td align="left">Linalool</td><td char="." align="char">54.8</td></tr><tr><td align="left"/><td align="left">1128</td><td align="left">&#x003b4;-Terpineol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1142</td><td align="left">Terpinen-4-ol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1152</td><td align="left">&#x003b1;-Terpineol</td><td char="." align="char">1.2</td></tr><tr><td align="left"/><td align="left">1192</td><td align="left"><italic>cis</italic>-Geraniol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1217</td><td align="left">Geraniol</td><td char="." align="char">0.5</td></tr><tr><td align="left"/><td align="left">1224</td><td align="left">Linalyl acetate</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1319</td><td align="left">&#x003b4;-Elemene</td><td char="." align="char">0.4</td></tr><tr><td align="left"/><td align="left">1331</td><td align="left">Neryl acetate</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1333</td><td align="left">&#x003b1;-Cubebene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1350</td><td align="left">Geranyl acetate</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1361</td><td align="left">&#x003b1;-Copaene</td><td char="." align="char">1.2</td></tr><tr><td align="left"/><td align="left">1369</td><td align="left">&#x003b2;-Bourbonene</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1375</td><td align="left">&#x003b2;-Elemene</td><td char="." align="char">1.2</td></tr><tr><td align="left"/><td align="left">1397</td><td align="left">&#x003b1;-Gurjunene</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1403</td><td align="left">Aristolene</td><td char="." align="char">1.0</td></tr><tr><td align="left"/><td align="left">1404</td><td align="left">&#x003b2;-Caryophyllene</td><td char="." align="char">1.9</td></tr><tr><td align="left"/><td align="left">1415</td><td align="left">&#x003b2;-Copaene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1425</td><td align="left">&#x003b1;-Bergamotene</td><td char="." align="char">0.5</td></tr><tr><td align="left"/><td align="left">1426</td><td align="left">Aromandendrene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1438</td><td align="left">Isoledene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1440</td><td align="left">Humulene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1448</td><td align="left">Alloaromadendrene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1462</td><td align="left">&#x003b3;-Gurjunene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1465</td><td align="left">&#x003b3;-Muurolene</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1467</td><td align="left">Guaia-1(10),11-diene</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1470</td><td align="left">Germacrene D</td><td char="." align="char">6.4</td></tr><tr><td align="left"/><td align="left">1475</td><td align="left">&#x003b2;-Selinene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1480</td><td align="left">&#x003b4;-Selinene</td><td char="." align="char">0.4</td></tr><tr><td align="left"/><td align="left">1483</td><td align="left">Cubebol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1487</td><td align="left">Bicyclogermacrene</td><td char="." align="char">5.0</td></tr><tr><td align="left"/><td align="left">1491</td><td align="left">&#x003b1;-Muurolene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1493</td><td align="left">&#x003b4;-Cadinene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1505</td><td align="left">&#x003b3;-Cadinene</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1511</td><td align="left"><italic>cis</italic>-&#x003b1;-Santalol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1551</td><td align="left">&#x003b2;-Maaliene</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1560</td><td align="left">Maaliol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1565</td><td align="left">Palustrol</td><td char="." align="char">0.2</td></tr><tr><td align="left"/><td align="left">1568</td><td align="left">Spathulenol</td><td char="." align="char">2.4</td></tr><tr><td align="left"/><td align="left">1575</td><td align="left">Caryophyllene oxide</td><td char="." align="char">0.5</td></tr><tr><td align="left"/><td align="left">1580</td><td align="left">Globulol</td><td char="." align="char">0.5</td></tr><tr><td align="left"/><td align="left">1585</td><td align="left">Salvial-4(14)-en-1-one</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1589</td><td align="left">Viridiflorol</td><td char="." align="char">0.3</td></tr><tr><td align="left"/><td align="left">1592</td><td align="left">Cubeban-11-ol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1600</td><td align="left">&#x003b2;-Eudesmol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1603</td><td align="left">Ledol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1612</td><td align="left">Neointermedeol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1622</td><td align="left">Junenol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1628</td><td align="left">Isospathulenol</td><td char="." align="char">0.3</td></tr><tr><td align="left"/><td align="left">1633</td><td align="left">Di-epi-1,10-cubenol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1646</td><td align="left"><italic>T</italic>-Muurolol</td><td char="." align="char">0.6</td></tr><tr><td align="left"/><td align="left">1650</td><td align="left">&#x003b4;-Cadinol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1652</td><td align="left">Cubenol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1658</td><td align="left">Aromadendrene oxide</td><td char="." align="char">0.3</td></tr><tr><td align="left"/><td align="left">1661</td><td align="left">&#x003b1;-Cadinol</td><td char="." align="char">1.0</td></tr><tr><td align="left"/><td align="left">1679</td><td align="left">Isoaromadendrene epoxide</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1688</td><td align="left">Ledene oxide</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1707</td><td align="left">Shyobunol</td><td char="." align="char">0.4</td></tr><tr><td align="left"/><td align="left">1727</td><td align="left">8-Hydroxylinalool</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">1984</td><td align="left">Manoyl oxide</td><td char="." align="char">0.7</td></tr><tr><td align="left"/><td align="left">2031</td><td align="left">Epimanool</td><td char="." align="char">0.5</td></tr><tr><td align="left"/><td align="left">2133</td><td align="left"><italic>trans</italic>-Geranylgeraniol</td><td char="." align="char">0.1</td></tr><tr><td align="left"/><td align="left">2166</td><td align="left">Sclareol</td><td char="." align="char">4.3</td></tr><tr><td align="left"/><td align="left"/><td align="left">Total</td><td char="." align="char">93.5</td></tr></tbody></table><table-wrap-foot><p>Compounds listed in order to their elution on the HP-1 column</p><p>RRI Relative retention indices calculated against C<sub>8</sub> &#x02013; C<sub>23</sub><italic>n</italic>-alkanes on the apolar HP-1 column</p><p>% calculated from GC/MS data</p></table-wrap-foot></table-wrap></p><p id="Par33">The EO of the dried flowers of <italic>S. ceratophylla</italic> grown in the middle of Jordan was dominate by oxygenated monoterpenes (58.28%) (Al Jaber, 2016). <italic>S. ceratophylla</italic> oil grown in Elaz&#x00131;&#x0011f;, Turkey is characterized by a high amount of germacrene D (27.4%) [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par34">G&#x000fc;rsoy et al. [<xref ref-type="bibr" rid="CR3">3</xref>] also reported that the composition of <italic>S. ceratophylla</italic> EO grown in Turkey, was dominated by &#x003b3;-muurolene (11.4%) and &#x003b1;-pinene (7.6%) as major compounds. Furthermore, the oils of <italic>S. ceratophylla</italic> grown in Kayseri, Elaz&#x00131;&#x0011f; and Ad&#x00131;yaman, Turkey were analyzed: &#x003b1;-Pinene (27.0%), &#x003b2;-pinene (16.3%) and &#x003b2;-caryophyllene (10.6%) were the major components in the Kayseri sample, &#x003b1;-pinene (24.6%) and &#x003b2;-pinene (10.3%) in the Elaz&#x00131;&#x0011f; samples, &#x003b1;-pinene (23.7%), 1,8-cineole (8.9%) and borneol (7.0%) in the Ad&#x00131;yaman sample. The <italic>S. ceratophylla</italic> EO from Iran was dominated by cis-thujopsene (10.9%), cyclopentadecanolide (6.1%), methyl linoleate (4.5%) and &#x003b1;-humulene (3.6%) [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par35">Our results revealed that <italic>S. ceratophylla</italic> EO, originated from southern Jordan showed significant differences compared with the oils obtained from samples grown in other locations and was distinguished by its high concentration of linalool. Our results also showed that this EO is distinct by containing the bicyclic diterpene alcohol sclareol, while this compound was absent in <italic>S. ceratophylla</italic> from Middle Jordan [<xref ref-type="bibr" rid="CR35">35</xref>], Turkey [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>] and Iran [<xref ref-type="bibr" rid="CR12">12</xref>]<italic>.</italic> This variation might be ascribed to the influence of various factors such as seasonal variation and some environmental conditions such as climate, heavy metals pollution and type of soil, in which the plants were grown [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Furthermore, harvesting time, temperature and drying period of plants, may also influence the yield of the EO and their phytochemical composition, because these factors are known to increase the concentration of some aromatic oil components, especially linalool [<xref ref-type="bibr" rid="CR37">37</xref>]. Kumar et al. [<xref ref-type="bibr" rid="CR38">38</xref>] reported higher contents of linalool in <italic>S. sclarea</italic> under high daily light exposure, while the highest content of germacrene D and sclareol required 50% and 75% of shade, respectively.</p><p id="Par36">Moreover, the EO of other <italic>Salvia</italic> species grown in Jordan were dominate by linalool as major component. Linalool was the major component in the oils of fresh and dry aerial parts of <italic>S. dominica</italic> (31.4% and 18.3%, respectively) [<xref ref-type="bibr" rid="CR39">39</xref>]. The main compound of EO extracted from fresh <italic>S. verbenaca</italic> was mainly linalool [<xref ref-type="bibr" rid="CR40">40</xref>].</p></sec><sec id="Sec23"><title>Cytotoxic Activity Against Cancer Cells</title><p id="Par37">The cytotoxic activity of <italic>S. ceratophylla</italic> EO and other extracts against cancer and non-cancer cell lines is summarize in Table <xref rid="Tab2" ref-type="table">2</xref>. To the best of our knowledge, the cytotoxic activity of <italic>S. ceratophylla</italic> EO is reporting here for the first time. The EO (up to a concentration of 100&#x000a0;&#x000b5;g/mL), linalool and other tested pure compounds (up to a concentration of 10&#x000a0;&#x000b5;g/mL) did not exhibit cytotoxic activities against all cell lines tested. In agreement with our results, other reports showed that linalool did not exhibit cytotoxic activity up to a concentration of 200&#x000a0;&#x003bc;g/mL against several cancer cell lines [<xref ref-type="bibr" rid="CR41">41</xref>]. Nevertheless, linalool had significant cytotoxic activity against various cancer cell lines, such as BCC-1/KMC, AGS, RTCC-1/KMC, U2OS, HeLa, H520, H661, OSCC-1/KMC, J82 [<xref ref-type="bibr" rid="CR42">42</xref>]. Furthermore, it enhanced the cytotoxic activity of doxorubicin against doxorubicin-resistant MCF-7 breast cancer cells [<xref ref-type="bibr" rid="CR43">43</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Cytotoxic activity (IC<sub>50</sub>) of <italic>S. ceratophylla</italic> EO, polar and non-polar extracts and pure compounds</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Sample code</th><th align="left">Cancer cell lines</th><th align="left"/><th align="left"/><th align="left"/><th align="left">Kidney epithelial</th><th align="left">Kidney fibroblast</th></tr><tr><th align="left"/><th align="left">SK-MEL</th><th align="left">KB</th><th align="left">BT-549</th><th align="left">SK-OV-3</th><th align="left">LLC-PK1</th><th align="left">Vero</th></tr><tr><th align="left"/><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>50</sub></th></tr><tr><th align="left"/><th align="left">&#x000b5;g/mL</th><th align="left">&#x000b5;g/mL</th><th align="left">&#x000b5;g/mL</th><th align="left">&#x000b5;g/mL</th><th align="left">&#x000b5;g/mL</th><th align="left">&#x000b5;g/mL</th></tr></thead><tbody><tr><td align="left">EO</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">A</td><td align="left">95</td><td align="left">70</td><td align="left">70</td><td align="left">100</td><td align="left">60</td><td align="left">&#x02009;&#x0003e;&#x02009;100</td></tr><tr><td align="left">B</td><td align="left">&#x02009;&#x0003e;&#x02009;100</td><td align="left">NA</td><td align="left">&#x02009;&#x0003e;&#x02009;100</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">C</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">D</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">Linalool</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">(-)trans-Caryophyllene</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">&#x003b1;-Terpineol</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">Doxorubicin</td><td align="left">0.8</td><td align="left">1.4</td><td align="left">0.85</td><td align="left">2</td><td align="left">1.2</td><td align="left">&#x02009;&#x0003e;&#x02009;5</td></tr></tbody></table><table-wrap-foot><p><italic>NA</italic> not active at 10&#x000a0;&#x000b5;g/mL for tested pure compound, and at 100&#x000a0;&#x000b5;g/mL for tested extracts</p></table-wrap-foot></table-wrap></p><p id="Par38">In addition, among all <italic>S. ceratophylla</italic> polar and nonpolar extracts tested, the hexane extract (A) exhibited slight cytotoxic activity against all tested cancer cell lines. The IC<sub>50</sub> values of A extract against SK-MEL, KB, BT-549, SK-OV-3, LLC-PK1 and VERO cells were 95, 70, 70, 100, 60, and&#x02009;&#x0003e;&#x02009;100&#x000a0;&#x000b5;g/mL, respectively.</p><p id="Par39">However, our results are in agreement with other previous reports. Abu-Dahab et al. [<xref ref-type="bibr" rid="CR16">16</xref>] showed that 70% ethanol extract of <italic>S. ceratophylla</italic> originated from Middle Jordan, exhibited low cytotoxic activity against several cancer cell lines. Furthermore, compared with other <italic>Salvia</italic> species from Jordan, the cytotoxic activity of <italic>S. ceratophylla</italic> 70% ethanol extract tested by using the sulforhodamine B colorimetric assay was comparable or even higher against the obesity-related HCT116 and Caco2 colorectal carcinoma cell lines. The cytotoxic activity of <italic>S. ceratophylla</italic> against other obesity-related colorectal cell lines including HT29, SW620, and PDL was low, but higher than other <italic>Salvia</italic> species tested [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] demonstrated that among various species of <italic>Salvia</italic>, <italic>S. ceratophylla</italic> methanol extract exhibited the strongest activity against human amelanotic melanoma (C32, CRL1585), and renal cell adenocarcinoma (ACHN, CRL1611) with IC<sub>50</sub> values of 20.8 and 27.2&#x000a0;&#x003bc;g/mL, respectively.</p><p id="Par40">However, the variation in the cytotoxic activity of <italic>Salvia</italic> species may be due to the variation in their chemical composition, which can be influence by various factors such as chemotype and environment [<xref ref-type="bibr" rid="CR4">4</xref>]. It was also reported that the cytotoxic activity of <italic>S.officinalis</italic> was affect by solvents used to obtain various extracts with various yields and quality of secondary metabolites [<xref ref-type="bibr" rid="CR44">44</xref>].</p></sec><sec id="Sec24"><title>Inhibition of Oxidative Stress and Anti-Inflammatory Activity</title><p id="Par41">Nitric oxide (NO) is a free radical and its production at high levels was associated with inflammation and cancer. The metabolic pathway, which is known as the L-arginine: NO pathway is the main source for NO production in mammalian cells by a group of enzymes known as the nitric oxide synthases (NOS). Inducible NOS (iNOS; NOS2; or type II NOS) is the enzyme responsible for the involvement of NO in inflammatory processes. Accordingly, the inhibition of NO production has been considered as a potential anti-inflammatory and cancer chemo-preventive strategy [<xref ref-type="bibr" rid="CR45">45</xref>]. On the other hand, the activation of NF-&#x003ba;B represents a mechanistic connection between chronic inflammation and tumorigenesis [<xref ref-type="bibr" rid="CR46">46</xref>]. The Specificity Protein 1 (Sp1) is a transcription factor, which binds GC/GT-rich promoter elements through three C2H2-type zinc fingers that are present in their C-terminal domains [<xref ref-type="bibr" rid="CR47">47</xref>]. Sp1 plays a major role in regulating the expression of genes involved in cell differentiation, cell cycle and apoptosis [<xref ref-type="bibr" rid="CR48">48</xref>]. As compared with normal tissues, the activity and / or expression levels of Sp 1 were increased in some tumors such as carcinomas of breast [<xref ref-type="bibr" rid="CR49">49</xref>], thyroid [<xref ref-type="bibr" rid="CR50">50</xref>], and pancreas [<xref ref-type="bibr" rid="CR51">51</xref>]. Sp1 plays an important regulatory role in controlling pathways of tumor development and progression. Thus, it may be an attractive therapeutic target for anticancer natural agents.</p><p id="Par42">The EO of several <italic>Salvia</italic> species were being report to inhibit iNOS [<xref ref-type="bibr" rid="CR52">52</xref>]. Therefore, we also evaluated, for the first time, the in vitro inhibiting intracellular oxidative stress activity of the EO and polar and nonpolar extracts <italic>S. ceratophylla</italic> from southern Jordan<italic>.</italic></p><p id="Par43">With exception of the EO, which did not decrease the oxidative stress, our results revealed that all other extracts exhibited antioxidant activity by inhibiting intracellular oxidative stress (Table <xref rid="Tab3" ref-type="table">3</xref>). The hexane (A) and ethyl acetate (B) extracts were the most active in decreasing oxidative stress. At the concentration 1000&#x000a0;&#x000b5;g/mL the decrease by the extracts was 50 and 47%, respectively, while at the concentration 500&#x000a0;&#x000b5;g/mL the decrease by the extracts was 56 and 25%, respectively. Among all tested pure compounds, only caryophyllene showed weak activity in decreasing oxidative stress by 35 and 31% at concentrations of 500 and 250&#x000a0;&#x000b5;g/mL, respectively.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Anti-inflammatory activity of <italic>S. ceratophylla</italic> essential oil, other extracts and pure compounds</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Sample code</th><th align="left">% decrease in</th><th align="left">Oxidative stress</th><th align="left">NO inhibition</th><th align="left">NF- &#x003ba;B inhibition</th><th align="left">Sp-1 inhibition</th></tr><tr><th align="left"/><th align="left">1000&#x000a0;&#x000b5;g/mL</th><th align="left">500&#x000a0;&#x000b5;g/mL</th><th align="left">IC<sub>50</sub> (&#x000b5;g/mL)</th><th align="left">IC<sub>50</sub> (&#x000b5;g/mL)</th><th align="left">IC<sub>50</sub> (&#x000b5;g/mL)</th></tr></thead><tbody><tr><td align="left">EO</td><td align="left">NA</td><td align="left">NA</td><td align="left">90</td><td align="left">38</td><td align="left">NA</td></tr><tr><td align="left">A</td><td align="left">50</td><td align="left">47</td><td align="left">32</td><td align="left">70</td><td align="left">70</td></tr><tr><td align="left">B</td><td align="left">56</td><td align="left">25</td><td align="left">30</td><td align="left">85</td><td align="left">160</td></tr><tr><td align="left">C</td><td align="left">43</td><td align="left">29</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left">D</td><td align="left">44</td><td align="left">21</td><td align="left">40</td><td align="left">150</td><td align="left">NA</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">500&#x000a0;&#x000b5;g/mL</th><th align="left">250&#x000a0;&#x000b5;g/mL</th><th align="left" colspan="3"/></tr></thead><tbody><tr><td align="left">Linalool</td><td align="left">NA</td><td align="left">NA</td><td align="left">18</td><td align="left">60</td><td align="left">NA</td></tr><tr><td align="left">Caryophyllene</td><td align="left">35</td><td align="left">31</td><td align="left">NA</td><td align="left">45</td><td align="left">48</td></tr><tr><td align="left">&#x003b1;-Terpineol</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">100</td><td align="left">NA</td></tr><tr><td align="left">Quercetin 25&#x000a0;&#x000b5;M</td><td align="left">75</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left">Parthenolide</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">0.48</td><td align="left">0.33</td><td align="left">&#x02013;</td></tr></tbody></table><table-wrap-foot><p><italic>NA</italic> Not active at tested concentration</p></table-wrap-foot></table-wrap></p><p id="Par44">The EO showed the lowest inhibition in NO production with an IC<sub>50</sub> 90&#x000a0;&#x000b5;g/mL and the highest inhibition activity against NF-&#x003ba;B with an IC<sub>50</sub> 38&#x000a0;&#x000b5;g/mL. At the same time, it did not inhibit the transcription factor Sp-1. The extracts A, B and D inhibited NO production and NF- &#x003ba;B with IC<sub>50</sub> values of 32, 30, and 40&#x000a0;&#x000b5;g/mL, and 70, 85 and 150&#x000a0;&#x000b5;g/mL, respectively. The two non-polar extracts (hexane and ethyl acetate, A and B) of <italic>S. ceratophylla</italic>, inhibited Sp-1 with IC<sub>50</sub> values of 70 and 160&#x000a0;&#x000b5;g/mL, respectively.</p><p id="Par45">Linalool was the only pure compound showing high and significant NO inhibition with an IC<sub>50</sub> value of 18&#x000a0;&#x000b5;g/mL. Linalool, caryophyllene and &#x003b1;-terpineol inhibited NF-&#x003ba;B activity with IC<sub>50</sub> values of 60, 45 and 100&#x000a0;&#x000b5;g/mL, respectively. Caryophyllene was the only pure compound, which inhibited Sp-1 with an IC<sub>50</sub> value of 48&#x000a0;&#x000b5;g/mL.</p><p id="Par46">The antioxidant activity of <italic>S. ceratophylla</italic> EO measured by different methods was moderate and slightly lower than the activity of <italic>S. palaestina</italic> essential oil [<xref ref-type="bibr" rid="CR3">3</xref>]. Moreover, <italic>S. officinalis</italic> EO from Jordan showed anti-inflammatory effects and significantly inhibited NO production stimulated by LPS in macrophages, without affecting cell viability, in concentrations up to 0.64 &#x003bc;L/mL [<xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par47">Nevertheless, the anti-inflammatory activity assessed by edema reduction was observed for <italic>S. ceratophylla</italic> ethylacetate extract with an ID<sub>50</sub> 98&#x000a0;&#x003bc;g/cm<sup>2</sup> compared with indomethacin, the hexane and methanol extract showed very low activity with an ID<sub>50</sub> of&#x02009;&#x0003e;&#x02009;300&#x000a0;&#x003bc;g/cm<sup>2</sup> [<xref ref-type="bibr" rid="CR6">6</xref>]. Moreover, using the FRAP method, <italic>S. ceratophylla</italic> exhibited significant antioxidant activity 290.7&#x000a0;&#x003bc;mol FeSO<sub>4</sub> eq/g of dried extract [<xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par48">However, the previously obtained results showed that linalool significantly inhibited carrageenin-induced hind paw edema (55%, <italic>p</italic>&#x02009;=&#x02009;0.03) at a dose of 25&#x000a0;mg/kg [<xref ref-type="bibr" rid="CR54">54</xref>]. Ma et al. [<xref ref-type="bibr" rid="CR55">55</xref>] reported that the effect of linalool on cigarette smoke induced acute lung inflammation and showed that it suppressed the activation of NF-&#x003ba;B in a dose-dependent manner. Hassan et al. [<xref ref-type="bibr" rid="CR46">46</xref>] showed that &#x003b1;-terpineol inhibited the growth of cell lung carcinoma through significant inhibition of the NF-&#x003ba;B pathway.</p><p id="Par49">However, in agreement with G&#x000fc;rsoy et al. [<xref ref-type="bibr" rid="CR3">3</xref>] it is important to mention that the anti-oxidative activity of EOs or extracts were link with the polarity of their chemical constituents. EOs with non-polar secondary metabolites such as terpenoids, were minimally or not active. The anti-inflammatory and radical scavenging activity of <italic>S. ceratophylla may</italic> be ascribe to the high total phenolic contents, thus contributing to their electron transfer/hydrogen donating capability [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]<italic>.</italic></p></sec><sec id="Sec25"><title>Antileishmanial and Antitrypanosomal Activities</title><p id="Par50">The present study provided for the first time, data on the activity of <italic>S. ceratophylla</italic> EO and other extracts (from Jordan) against <italic>T. brucei</italic> and <italic>L. donovani</italic> in promastigote and amastigote stages. Furthermore, this study demonstrated the antiprotozoal activity of pure compounds (linalool, &#x003b1;&#x02013;terpineol and &#x003b2;-caryophyllene).</p><p id="Par51">EO and extracts of <italic>S. ceratophylla</italic> and pure compounds did not exhibit antileishmanial activity against extracellular (promastigote) and intracellular (amastigote) forms of <italic>L. donovani</italic> at all tested concentrations (Table <xref rid="Tab4" ref-type="table">4</xref>). On the other hand, the Jordan <italic>S. ceratophylla</italic> exhibited significant antitrypanosomal activity against <italic>T. brucei.</italic> The EO showed higher antitrypanosomal activity with IC<sub>50</sub> and IC<sub>90</sub> values of 2.65 and 3.61&#x000a0;&#x000b5;g/mL, respectively. The inhibiting activity of the EO was better than that of the control (&#x003b1;-difluoromethylornithine) with IC<sub>50</sub> and IC<sub>90</sub> values of 4.792 and 7.76&#x000a0;&#x000b5;g/mL. Among all extracts, the Ethyl acetate extract (B) was the only one that exhibited moderate antitrypanosomal activity against <italic>T. brucei</italic> with IC<sub>50</sub> and IC<sub>90</sub> values of 15.78 and 19.28&#x000a0;&#x000b5;g/mL, respectively. Among the pure compounds, &#x003b1;-terpineol was the only compound that exhibited antitrypanosomal activity against <italic>T. brucei</italic> similar to the control (&#x003b1;-difluoromethylornithine) with IC<sub>50</sub> and IC<sub>90</sub> values of 6.04 and 8.22&#x000a0;&#x000b5;g/mL, respectively.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Antiprotozoal activity of <italic>S. ceratophylla</italic> essential oil, other extracts and pure compounds (only the antitrypanosomal activity)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Tested sample</th><th align="left" colspan="2"><italic>L. donovani Promastigote</italic></th><th align="left" colspan="2"><italic>L. donovani Amastigote</italic></th><th align="left" colspan="2"><italic>L. donovani Amastigote</italic>&#x02009;+&#x02009;THP1</th><th align="left" colspan="2"><italic>T. brucei</italic></th><th align="left" colspan="2">THP1 cells toxicity</th><th align="left" rowspan="2">Tested concentr-ations (&#x000b5;g/mL)</th></tr><tr><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>90</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>90</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>90</sub></th><th align="left">IC<sub>50</sub></th><th align="left">IC<sub>90</sub></th></tr></thead><tbody><tr><td align="left"><p>EO</p><p>A</p><p>B</p><p>C</p><p>D</p><p>Linalool</p><p>&#x003b1; -terpineol</p><p>&#x003b2;-Caryophyllene</p><p>Amphotericin B</p><p>Pentamidine</p><p>&#x003b1;-difluorome-thylornithine</p></td><td align="left"><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>0.140</p><p>1.024</p><p>NT</p></td><td align="left"><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>0.324</p><p>9.280</p><p>NT</p></td><td align="left"><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>0.181</p><p>3.797</p><p>NT</p></td><td align="left"><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>T</p></td><td align="left"><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NT</p></td><td align="left"><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NT</p></td><td align="left"><p>2.65</p><p>NA</p><p>15.78</p><p>NA</p><p>NA</p><p>NA</p><p>6.04</p><p>NA</p><p>NT</p><p>NT</p><p>4.792</p></td><td char="&#x02013;" align="char"><p>3.65</p><p>NA</p><p>19.28</p><p>NA</p><p>NA</p><p>NA</p><p>8.22</p><p>NA</p><p>0.426</p><p>&#x02013;</p><p>7.760</p></td><td char="&#x02013;" align="char"><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>0.375</p><p>&#x02013;</p><p>NT</p></td><td align="left"><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>NA</p><p>0.190</p><p>1.735</p><p>NT</p></td><td align="left"><p>20&#x02013;0.8</p><p>20&#x02013;0.8</p><p>20&#x02013;0.8</p><p>20&#x02013;0.8</p><p>20&#x02013;0.8</p><p>10&#x02013;0.4</p><p>10&#x02013;0.4</p><p>10&#x02013;0.4</p><p>2.0&#x02013;0.08</p><p>10&#x02013;0.4</p><p>20&#x02013;0.8</p></td></tr></tbody></table><table-wrap-foot><p><italic>NA</italic> not active at tested concentration, <italic>NT</italic> not tested against listed protozoans</p></table-wrap-foot></table-wrap></p><p id="Par52">Interestingly, the results of human acute monocytic leukemia cells toxicity (THP1) showed that the <italic>S. ceratophylla</italic> EO, Ethyl acetate extract (B) and &#x003b1;-terpineol did not exhibit cytotoxic effects on mammalian cells at the concentrations tested.</p><p id="Par53">Other authors stated that extracts obtained from other <italic>Salvia</italic> species led to similar results than those of <italic>S. ceratophylla</italic> extracts, such as the activity of <italic>S. officinalis</italic> methanol extract from leaves against promastigote and amastigote forms of <italic>L. major</italic> [<xref ref-type="bibr" rid="CR57">57</xref>]. Moreover, the liquid form of <italic>S. officinalis</italic> extract distributed in the German market did not show remarkable antileishmanial activity against <italic>L. donovani</italic> [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par54">Morales et al. [<xref ref-type="bibr" rid="CR25">25</xref>] studied the antileishmanial activity of various EO components such as linalool, carvacrol, geraniol and terpinen-4-ol against <italic>L. infantum</italic> promastigotes. Accordingly, among the compounds tested, carvacrol exhibited the highest activity at the lowest concentration of 6.25&#x000a0;&#x000b5;g/mL followed by linalool, which exhibited dose-dependent antileishmanial activity. At a concentration of 37.5&#x000a0;&#x000b5;g/mL the inhibitory activity of linalool was similar to the control drug (Pentamidine). Moreover, linalool, the main EO component of <italic>Croton cajucara</italic> reduced the viability of <italic>L. amazonensis</italic> promastigotes at very low concentrations (MIC, 85.0&#x000a0;pg/ml) and presented no cytotoxic effects against mammalian cells [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par55">&#x0015a;lusarczyk et al. [63] showed that among 880 plant and fungal extracts, the dichloromethane extract of <italic>S. miltiorrhiza</italic> was the only extract that inhibited 97% of <italic>T. brucei rhodesiense</italic> growth at the lowest concentration tested (0.81&#x000a0;&#x003bc;g/mL). Accordingly, the antitrypanosomal activity of <italic>S. miltiorrhiza</italic> dichloromethane extract was correlate with the presence of tanshinone-type diterpenoids, which also exhibited antitrypanosomal activity with IC<sub>50</sub> values of 0.5&#x000a0;&#x000b5;M to over 30&#x000a0;&#x000b5;M against <italic>T. brucei rhodesiense</italic> [<xref ref-type="bibr" rid="CR58">58</xref>].</p><p id="Par56">Both, minor compound (nerolidol) and major compound (linalool) of <italic>Strychnos spinosa</italic> EO demonstrated high and selective activity towards <italic>Trypanosoma</italic> (SI&#x02009;=&#x02009;35.7 and&#x02009;&#x0003e;&#x02009;40, respectively, and IC<sub>50</sub>&#x02009;=&#x02009;1.7 and 2.5&#x000a0;&#x000b5;g/mL, respectively). &#x003b1;-Terpineol was slightly active against <italic>T. brucei brucei</italic> blood stream forms [<xref ref-type="bibr" rid="CR59">59</xref>]. However, these authors also reported that the discrepancy in the results might be due to different used methods and/or due to differences in stereoisomeric forms of the compounds tested.</p></sec></sec><sec id="Sec26"><title>Conclusion</title><p id="Par57">The present study revealed that <italic>S. ceratophylla</italic> EO from Jordan was characterize by a high amount of linalool. Additionally, the EO exhibited significant antitrypanosomal activity against <italic>T. brucei.</italic> Moreover, the inhibitory activity of <italic>S. ceratophylla</italic> EO against <italic>T. brucei</italic> was stronger than that of the control (&#x003b1;-difluoromethylornithine).</p><p id="Par58">This study highlights the potential of this EO as a good candidate for the treatment of the hard to cure neglected trypanosomiasis infections, also it is demonstrating that <italic>S. ceratophylla</italic> bears promising therapeutic potential for further drug development. Importantly, this work also clearly validated some of the traditional medicinal uses of <italic>Salvia</italic> species.</p></sec></body><back><ack><title>Acknowledgements</title><p>This work has been conducted during the Fulbright visiting scholarship awarded to Prof. Dr. Mohammad Sanad Abu-Darwish during his Sabbatical leave from Al-Balqa&#x02019; Applied University, Al-Salt, Jordan, at the National Center for Natural Products Research, School of Pharmacy, University of Mississippi, USA. The authors thank the Dean of Scientific Research, Al-Balqa Applied University, Jordan, the Binational Fulbright Commission in Jordan, Council for International Exchange of Scholars (CIES), and Institute of International Education (IIE), USA. This work was also supported by Foundation for Science and Technology (FCT), Portugal (Strategic Projects UID/NEU/04539/2013 ,and UID/NEU/04539/2019,&#x000a0;UIDB/04539/2020 and UIDP/04539/2020 (CIBB)).</p></ack><notes><title>Compliance with Ethical Standards</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par59">The authors declare that there is no conflict of interest.</p></notes></notes><ref-list id="Bib1"><title>References
</title><ref id="CR1"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Taifour</surname><given-names>H</given-names></name><name><surname>El-Oqlah</surname><given-names>A</given-names></name></person-group><source>Jordan plant red list</source><year>2015</year><publisher-loc>Jordan</publisher-loc><publisher-name>Royal Botanic Garden</publisher-name></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oran</surname><given-names>SA</given-names></name></person-group><source>Int. J. Biodiv. Cons.</source><year>2014</year><volume>6</volume><fpage>28</fpage><lpage>40</lpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;rsoy</surname><given-names>N</given-names></name><name><surname>Tepe</surname><given-names>B</given-names></name><name><surname>Akpulat</surname><given-names>HA</given-names></name></person-group><source>Rec. Nat. Prod.</source><year>2012</year><volume>6</volume><fpage>278</fpage><lpage>287</lpage></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Bakri</surname><given-names>A</given-names></name><name><surname>Othman</surname><given-names>G</given-names></name><name><surname>Afifi</surname><given-names>F</given-names></name><name><surname>Pharmacog</surname><given-names>F</given-names></name></person-group><source>Mag.</source><year>2010</year><volume>6</volume><fpage>264</fpage><lpage>270</lpage></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasabri</surname><given-names>V</given-names></name><name><surname>Afifi</surname><given-names>FU</given-names></name><name><surname>Abu-Dahab</surname><given-names>R</given-names></name><name><surname>Mhaidat</surname><given-names>N</given-names></name><name><surname>Bustanji</surname><given-names>YK</given-names></name><name><surname>Abaza</surname><given-names>IM</given-names></name><name><surname>Mashallah</surname><given-names>S</given-names></name></person-group><source>Rev. Roum. Chim.</source><year>2014</year><volume>59</volume><fpage>693</fpage><lpage>705</lpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shehadeh</surname><given-names>MB</given-names></name><name><surname>Sosa</surname><given-names>S</given-names></name><name><surname>Suaifan</surname><given-names>G</given-names></name><name><surname>Darwish</surname><given-names>RM</given-names></name></person-group><source>Jordan J. Pharm. Sci.</source><year>2014</year><volume>7</volume><fpage>153</fpage><lpage>161</lpage></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardile</surname><given-names>V</given-names></name><name><surname>Russo</surname><given-names>A</given-names></name><name><surname>Formisano</surname><given-names>C</given-names></name><name><surname>Rigano</surname><given-names>D</given-names></name><name><surname>Senatore</surname><given-names>F</given-names></name><name><surname>Arnold</surname><given-names>NA</given-names></name><name><surname>Piozzi</surname><given-names>F</given-names></name></person-group><source>J. Ethnopharmacol.</source><year>2009</year><volume>126</volume><fpage>265</fpage><lpage>272</lpage><?supplied-pmid 19715748?><pub-id pub-id-type="pmid">19715748</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Darwish</surname><given-names>MS</given-names></name></person-group><source>Int. J. Phytomed.</source><year>2014</year><volume>6</volume><fpage>384</fpage><lpage>390</lpage></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bero</surname><given-names>J</given-names></name><name><surname>Fr&#x000e9;d&#x000e9;rich</surname><given-names>M</given-names></name><name><surname>Quetin-Leclercq</surname><given-names>J</given-names></name></person-group><source>J. Phar. Pharmacol.</source><year>2009</year><volume>61</volume><fpage>1401</fpage><lpage>1433</lpage></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosun</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Cal&#x000ed;n-S&#x000e1;nchez</surname><given-names>&#x000c1;</given-names></name><name><surname>Hysenaj</surname><given-names>X</given-names></name><name><surname>Carbonell-Barrachina</surname><given-names>A</given-names></name></person-group><source>Trop. J. Pharm. Res.</source><year>2014</year><volume>13</volume><fpage>937</fpage><lpage>942</lpage></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokoka</surname><given-names>TA</given-names></name><name><surname>Zimmermann</surname><given-names>S</given-names></name><name><surname>Julianti</surname><given-names>T</given-names></name><name><surname>Hata</surname><given-names>Y</given-names></name><name><surname>Moodley</surname><given-names>N</given-names></name><name><surname>Cal</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>M</given-names></name><name><surname>Kaiser</surname><given-names>M</given-names></name><name><surname>Brun</surname><given-names>R</given-names></name><name><surname>Koorbanally</surname><given-names>N</given-names></name><name><surname>Hamburger</surname><given-names>M</given-names></name></person-group><source>Planta Med.</source><year>2011</year><volume>77</volume><fpage>1663</fpage><lpage>1667</lpage><?supplied-pmid 21412695?><pub-id pub-id-type="pmid">21412695</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>M</given-names></name><name><surname>Yousefi</surname><given-names>M</given-names></name><name><surname>Habibi</surname><given-names>Z</given-names></name><name><surname>Rahmati</surname><given-names>S</given-names></name><name><surname>Imanzadeh</surname><given-names>G</given-names></name></person-group><source>J. Ess. Oil Bear. Plants</source><year>2010</year><volume>13</volume><fpage>774</fpage><lpage>778</lpage></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ba&#x0011f;ci</surname><given-names>E</given-names></name><name><surname>Ko&#x000e7;ak</surname><given-names>A</given-names></name></person-group><source>Sci. Eng. J. F&#x00131;rat. Univ.</source><year>2007</year><volume>19</volume><fpage>435</fpage><lpage>442</lpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ba&#x0015f;er</surname><given-names>KHC</given-names></name><name><surname>A&#x0011f;alar</surname><given-names>HG</given-names></name><name><surname>Celep</surname><given-names>F</given-names></name><name><surname>Kahraman</surname><given-names>A</given-names></name><name><surname>Do&#x0011f;an</surname><given-names>M</given-names></name><name><surname>Demirci</surname><given-names>B</given-names></name><name><surname>Turk</surname><given-names>B</given-names></name></person-group><source>J. Pharm. Sci.</source><year>2015</year><volume>12</volume><fpage>53</fpage><lpage>58</lpage></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Jaber</surname><given-names>HI</given-names></name></person-group><source>Jordan J. Chem.</source><year>2016</year><volume>11</volume><fpage>108</fpage><lpage>119</lpage></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Dahab</surname><given-names>R</given-names></name><name><surname>Afifi</surname><given-names>F</given-names></name><name><surname>Kasabri</surname><given-names>V</given-names></name><name><surname>Majdalawi</surname><given-names>L</given-names></name><name><surname>Naffa</surname><given-names>R</given-names></name></person-group><source>Pharmac. Mag.</source><year>2012</year><volume>8</volume><fpage>319</fpage><lpage>324</lpage></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loizzo</surname><given-names>MR</given-names></name><name><surname>Abouali</surname><given-names>M</given-names></name><name><surname>Salehi</surname><given-names>P</given-names></name><name><surname>Sonboli</surname><given-names>A</given-names></name><name><surname>Kanani</surname><given-names>M</given-names></name><name><surname>Menichini</surname><given-names>F</given-names></name><name><surname>Tundis</surname><given-names>R</given-names></name><name><surname>Nat</surname><given-names>R</given-names></name></person-group><source>Prod. Res.</source><year>2014</year><volume>24</volume><fpage>2278</fpage><lpage>2285</lpage></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>I</given-names></name><name><surname>Kartal</surname><given-names>M</given-names></name><name><surname>Naz</surname><given-names>Q</given-names></name><name><surname>Ejaz</surname><given-names>A</given-names></name><name><surname>Yilmaz</surname><given-names>G</given-names></name><name><surname>Kan</surname><given-names>Y</given-names></name><name><surname>Konuklugil</surname><given-names>B</given-names></name><name><surname>Sener</surname><given-names>B</given-names></name><name><surname>Choudhary</surname><given-names>MI</given-names></name></person-group><source>Food Chem.</source><year>2007</year><volume>103</volume><fpage>1247</fpage><lpage>1254</lpage></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peana</surname><given-names>AT</given-names></name><name><surname>D'Aquila</surname><given-names>PS</given-names></name><name><surname>Panin</surname><given-names>F</given-names></name><name><surname>Serra</surname><given-names>G</given-names></name><name><surname>Pippia</surname><given-names>P</given-names></name><name><surname>Moretti</surname><given-names>MDL</given-names></name></person-group><source>Phytomedicine</source><year>2002</year><volume>9</volume><fpage>721</fpage><lpage>726</lpage><?supplied-pmid 12587692?><pub-id pub-id-type="pmid">12587692</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamatou</surname><given-names>GPP</given-names></name><name><surname>Makunga</surname><given-names>NP</given-names></name><name><surname>Ramogola</surname><given-names>WPN</given-names></name><name><surname>Viljoen</surname><given-names>AM</given-names></name></person-group><source>J. Ethnopharmacol.</source><year>2008</year><volume>119</volume><fpage>664</fpage><lpage>672</lpage><?supplied-pmid 18640254?><pub-id pub-id-type="pmid">18640254</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montesino</surname><given-names>NL</given-names></name><name><surname>Kaiser</surname><given-names>M</given-names></name><name><surname>Brun</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>TJ</given-names></name></person-group><source>Molecules</source><year>2015</year><volume>20</volume><fpage>14118</fpage><lpage>14138</lpage><pub-id pub-id-type="pmid">26248069</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Alencar</surname><given-names>MVOB</given-names></name><name><surname>Castroe Sousa</surname><given-names>JM</given-names></name><name><surname>Rolim</surname><given-names>HML</given-names></name><name><surname>Medeiros</surname><given-names>MGF</given-names></name><name><surname>Cerqueira</surname><given-names>GS</given-names></name><name><surname>Almeida</surname><given-names>FRC</given-names></name><name><surname>Cit&#x000f3;</surname><given-names>AMGL</given-names></name><name><surname>Ferreira</surname><given-names>PMP</given-names></name><name><surname>Lopes</surname><given-names>JAD</given-names></name><name><surname>Melo-Cavalcante</surname><given-names>AAC</given-names></name><name><surname>Islam</surname><given-names>MT</given-names></name></person-group><source>Phytother. Res.</source><year>2017</year><volume>31</volume><fpage>175</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">27896890</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serakta</surname><given-names>M</given-names></name><name><surname>Djerrou</surname><given-names>Z</given-names></name><name><surname>Mansour-Djaalab</surname><given-names>H</given-names></name><name><surname>Kahlouche-Riachi</surname><given-names>F</given-names></name><name><surname>Hamimed</surname><given-names>S</given-names></name><name><surname>Trifa</surname><given-names>W</given-names></name><name><surname>Belkhiri</surname><given-names>A</given-names></name><name><surname>Edikra</surname><given-names>N</given-names></name><name><surname>Hamdi Pacha</surname><given-names>Y</given-names></name></person-group><source>Afr. J. Tradit. Complement. Altern. Med.</source><year>2013</year><volume>10</volume><fpage>427</fpage><lpage>430</lpage><?supplied-pmid 24146470?><pub-id pub-id-type="pmid">24146470</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>MSS</given-names></name><name><surname>Mendonca-Filho</surname><given-names>RR</given-names></name><name><surname>Bizzo</surname><given-names>HR</given-names></name><name><surname>Rodrigues</surname><given-names>IA</given-names></name><name><surname>Soares</surname><given-names>RMA</given-names></name><name><surname>Souto-Padr&#x000f3;n</surname><given-names>T</given-names></name><name><surname>Alviano</surname><given-names>CS</given-names></name><name><surname>Lopes</surname><given-names>AH</given-names></name></person-group><source>Antimicrob. Agents Chemother.</source><year>2003</year><volume>47</volume><fpage>1895</fpage><lpage>1901</lpage><pub-id pub-id-type="pmid">12760864</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>M</given-names></name><name><surname>Navarro</surname><given-names>MC</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>J</given-names></name><name><surname>Valero</surname><given-names>A</given-names></name><name><surname>Lara</surname><given-names>AM</given-names></name><name><surname>Bar&#x000f3;n</surname><given-names>S</given-names></name><name><surname>Morillas</surname><given-names>F</given-names></name></person-group><source>Rev. Ibero-Latinoamericana Paras.</source><year>2009</year><volume>68</volume><issue>1</issue><fpage>65</fpage><lpage>72</lpage></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>AO</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T</given-names></name><name><surname>Dias</surname><given-names>BP</given-names></name><name><surname>Veiga</surname><given-names>VF</given-names></name><name><surname>Pinto</surname><given-names>AC</given-names></name><name><surname>Nakamura</surname><given-names>CV</given-names></name></person-group><source>J. Ethnopharmacol.</source><year>2008</year><volume>120</volume><fpage>204</fpage><lpage>208</lpage><?supplied-pmid 18775772?><pub-id pub-id-type="pmid">18775772</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nibret</surname><given-names>E</given-names></name><name><surname>Wink</surname><given-names>M</given-names></name></person-group><source>Phytomedicine</source><year>2010</year><volume>17</volume><fpage>911</fpage><lpage>920</lpage><?supplied-pmid 20359874?><pub-id pub-id-type="pmid">20359874</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Council of Europe</collab></person-group><source>European pharmacopoeia</source><year>1997</year><edition>3</edition><publisher-loc>Strasbourg</publisher-loc><publisher-name>Council of Europe</publisher-name></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>NW</given-names></name></person-group><source>J. Chromatogr. A</source><year>1990</year><volume>503</volume><fpage>1</fpage><lpage>24</lpage></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borenfreund</surname><given-names>E</given-names></name><name><surname>Babich</surname><given-names>H</given-names></name><name><surname>Martin-Alguacil</surname><given-names>N</given-names></name></person-group><article-title>vitro Cell</article-title><source>Dev. Biol.</source><year>1990</year><volume>26</volume><fpage>1030</fpage><lpage>1034</lpage></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taweel</surname><given-names>AM</given-names></name><name><surname>El-Shafae</surname><given-names>AM</given-names></name><name><surname>Perveen</surname><given-names>S</given-names></name><name><surname>Fawzy</surname><given-names>GA</given-names></name><name><surname>Khan</surname><given-names>SI</given-names></name></person-group><source>Int. J. Pharm.</source><year>2015</year><volume>11</volume><fpage>372</fpage><lpage>376</lpage></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>SK</given-names></name><name><surname>Sahu</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>LA</given-names></name><name><surname>Tekwani</surname><given-names>BL</given-names></name></person-group><source>J. Vis. Exp.</source><year>2012</year><volume>70</volume><fpage>4054</fpage></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Jacob</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>L</given-names></name><name><surname>Tekwani</surname><given-names>B</given-names></name></person-group><source>BMC Complement. Altern. Med.</source><year>2016</year><volume>16</volume><fpage>131</fpage><?supplied-pmid 27193901?><pub-id pub-id-type="pmid">27193901</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maksimovic</surname><given-names>M</given-names></name><name><surname>Vidic</surname><given-names>D</given-names></name><name><surname>Milos</surname><given-names>M</given-names></name><name><surname>Olic</surname><given-names>MES</given-names></name><name><surname>Zic</surname><given-names>SA</given-names></name><name><surname>Siljak-Yakovlev</surname><given-names>S</given-names></name></person-group><source>Biochem. Syst. Ecol.</source><year>2007</year><volume>35</volume><fpage>473</fpage><lpage>478</lpage></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Darwish</surname><given-names>M</given-names></name><name><surname>Abu-Dieyeh</surname><given-names>Z</given-names></name><name><surname>Al-Fraihat</surname><given-names>A</given-names></name><name><surname>Al-dalain</surname><given-names>S</given-names></name><name><surname>Afifi</surname><given-names>F</given-names></name><name><surname>Al-Tabbal</surname><given-names>J</given-names></name></person-group><source>Int. J. Agri. Biol.</source><year>2010</year><volume>13</volume><fpage>981</fpage><lpage>985</lpage></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname><given-names>AC</given-names></name><name><surname>Barroso</surname><given-names>JG</given-names></name><name><surname>Pedro</surname><given-names>LG</given-names></name><name><surname>Scheffer</surname><given-names>JJC</given-names></name></person-group><article-title>Flavour</article-title><source>Fragr. J.</source><year>2008</year><volume>23</volume><fpage>213</fpage><lpage>226</lpage></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho-Filho</surname><given-names>JLS</given-names></name><name><surname>Blank</surname><given-names>AF</given-names></name><name><surname>Alves</surname><given-names>PB</given-names></name><name><surname>Ehlert</surname><given-names>PAD</given-names></name><name><surname>Melo</surname><given-names>AS</given-names></name><name><surname>Cavalcanti</surname><given-names>SCH</given-names></name><name><surname>Arrigoni-Blank</surname><given-names>MF</given-names></name><name><surname>Silva-Mann</surname><given-names>R</given-names></name></person-group><source>Rev. Bras. Farmacogn.</source><year>2006</year><volume>16</volume><fpage>24</fpage><lpage>30</lpage></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Pathania</surname><given-names>V</given-names></name></person-group><source>J. Ess. Oil Res.</source><year>2013</year><volume>25</volume><fpage>23</fpage><lpage>32</lpage></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>M</given-names></name><name><surname>Abu-Daha</surname><given-names>R</given-names></name><name><surname>Afifi</surname><given-names>F</given-names></name></person-group><article-title>Jordan</article-title><source>J. Pharm. Sci.</source><year>2013</year><volume>6</volume><fpage>40</fpage><lpage>47</lpage></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Jaber</surname><given-names>HIJ</given-names></name></person-group><source>Essent. Oil Bear. Pl.</source><year>2015</year><volume>18</volume><fpage>718</fpage><lpage>724</lpage></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>SLD</given-names></name><name><surname>Figueiredo</surname><given-names>PM</given-names></name><name><surname>Yano</surname><given-names>T</given-names></name></person-group><source>Acta Amazo.</source><year>2007</year><volume>37</volume><fpage>281</fpage><lpage>286</lpage></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>LC</given-names></name><name><surname>Chiang</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>MY</given-names></name><name><surname>Ng</surname><given-names>LT</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><source>Am. J. Chin. Med.</source><year>2003</year><volume>31</volume><fpage>37</fpage><lpage>46</lpage><?supplied-pmid 12723753?><pub-id pub-id-type="pmid">12723753</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravizza</surname><given-names>R</given-names></name><name><surname>Garibold</surname><given-names>MB</given-names></name><name><surname>Molteni</surname><given-names>R</given-names></name><name><surname>Monti</surname><given-names>E</given-names></name></person-group><source>Oncol. Rep.</source><year>2008</year><volume>20</volume><fpage>625</fpage><lpage>630</lpage><?supplied-pmid 18695915?><pub-id pub-id-type="pmid">18695915</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alzeer</surname><given-names>J</given-names></name><name><surname>Vummidi</surname><given-names>BR</given-names></name><name><surname>Arafeh</surname><given-names>R</given-names></name><name><surname>Rimawi</surname><given-names>W</given-names></name><name><surname>Saleem</surname><given-names>H</given-names></name><name><surname>Luedtke</surname><given-names>NW</given-names></name></person-group><source>J. Med. Plants Res.</source><year>2014</year><volume>8</volume><fpage>408</fpage><lpage>415</lpage></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zamora</surname><given-names>R</given-names></name><name><surname>Vodovotz</surname><given-names>Y</given-names></name><name><surname>Billiar</surname><given-names>TR</given-names></name></person-group><source>Mol. Med.</source><year>2000</year><volume>6</volume><fpage>347</fpage><lpage>373</lpage><?supplied-pmid 10952018?><pub-id pub-id-type="pmid">10952018</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>SB</given-names></name><name><surname>Gali-Muhtasib</surname><given-names>H</given-names></name><name><surname>G&#x000f6;ransson</surname><given-names>H</given-names></name><name><surname>Larsson</surname><given-names>R</given-names></name></person-group><source>Anticancer Res.</source><year>2010</year><volume>30</volume><fpage>1911</fpage><lpage>1919</lpage><?supplied-pmid 20651334?><pub-id pub-id-type="pmid">20651334</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suske</surname><given-names>G</given-names></name></person-group><source>Gene</source><year>1999</year><volume>238</volume><fpage>291</fpage><lpage>300</lpage><?supplied-pmid 10570957?><pub-id pub-id-type="pmid">10570957</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>AR</given-names></name><name><surname>Black</surname><given-names>JD</given-names></name><name><surname>Azizkhan-Clifford</surname><given-names>J</given-names></name></person-group><source>J. Cell Phys.</source><year>2001</year><volume>188</volume><fpage>143</fpage><lpage>160</lpage></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelrahim</surname><given-names>M</given-names></name><name><surname>Samudio</surname><given-names>I</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Burghardt</surname><given-names>R</given-names></name><name><surname>Safe</surname><given-names>S</given-names></name></person-group><source>J. Bio. Chem.</source><year>2002</year><volume>277</volume><fpage>28815</fpage><lpage>28822</lpage><pub-id pub-id-type="pmid">12052832</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiefari</surname><given-names>E</given-names></name><name><surname>Brunetti</surname><given-names>A</given-names></name><name><surname>Arturi</surname><given-names>F</given-names></name><name><surname>Bidart</surname><given-names>J-M</given-names></name><name><surname>Russo</surname><given-names>D</given-names></name><name><surname>Schlumberger</surname><given-names>M</given-names></name><name><surname>Filetti</surname><given-names>S</given-names></name></person-group><source>BMC Cancer</source><year>2002</year><volume>2</volume><issue>1</issue><fpage>35</fpage><?supplied-pmid 12475396?><pub-id pub-id-type="pmid">12475396</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>NY</given-names></name><name><surname>Woda</surname><given-names>BA</given-names></name><name><surname>Banner</surname><given-names>BF</given-names></name><name><surname>Whalen</surname><given-names>GF</given-names></name><name><surname>Dresser</surname><given-names>KA</given-names></name><name><surname>Lu</surname><given-names>D</given-names></name></person-group><source>Cancer Epid. Prev. Biom.</source><year>2008</year><volume>17</volume><fpage>1648</fpage><lpage>1652</lpage></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durgha</surname><given-names>H</given-names></name><name><surname>Thirugnanasampandan</surname><given-names>R</given-names></name><name><surname>Ramya</surname><given-names>G</given-names></name><name><surname>Ramanth</surname><given-names>MG</given-names></name></person-group><source>J. King Saud Uni.-Sci.</source><year>2015</year><volume>28</volume><fpage>390</fpage><lpage>395</lpage></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Darwish</surname><given-names>MS</given-names></name><name><surname>Cabral</surname><given-names>C</given-names></name><name><surname>Ferreira</surname><given-names>IV</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>MJ</given-names></name><name><surname>Cavaleiro</surname><given-names>C</given-names></name><name><surname>Cruz</surname><given-names>MT</given-names></name><name><surname>Salgueiro</surname><given-names>L</given-names></name></person-group><source>Biomed. Res. Int.</source><year>2013</year><volume>2013</volume><fpage>538940</fpage><?supplied-pmid 24224168?><pub-id pub-id-type="pmid">24224168</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SilveiraeS&#x000e1;</surname><given-names>R</given-names></name><name><surname>Andrade</surname><given-names>LN</given-names></name><name><surname>Sousa</surname><given-names>DP</given-names></name></person-group><source>Molecules</source><year>2013</year><volume>18</volume><fpage>1227</fpage><lpage>1254</lpage><pub-id pub-id-type="pmid">23334570</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name></person-group><source>Int. Immunopharmacol.</source><year>2015</year><volume>29</volume><fpage>708</fpage><lpage>713</lpage><?supplied-pmid 26432179?><pub-id pub-id-type="pmid">26432179</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosun</surname><given-names>M</given-names></name><name><surname>Ercisli</surname><given-names>S</given-names></name><name><surname>Sengul</surname><given-names>M</given-names></name><name><surname>Ozer</surname><given-names>H</given-names></name><name><surname>Polat</surname><given-names>T</given-names></name><name><surname>Ozturk</surname><given-names>E</given-names></name></person-group><source>Biol Res.</source><year>2009</year><volume>42</volume><fpage>175</fpage><lpage>181</lpage><?supplied-pmid 19746262?><pub-id pub-id-type="pmid">19746262</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikmehr</surname><given-names>B</given-names></name><name><surname>Ghaznavi</surname><given-names>H</given-names></name><name><surname>Rahbar</surname><given-names>A</given-names></name><name><surname>Sadr</surname><given-names>S</given-names></name><name><surname>Mehrzadi</surname><given-names>S</given-names></name><name><surname>Chin</surname><given-names>S</given-names></name></person-group><source>J. Nat. Med.</source><year>2014</year><volume>12</volume><fpage>423</fpage><lpage>427</lpage></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x0015a;lusarczyk</surname><given-names>S</given-names></name><name><surname>Zimmermann</surname><given-names>S</given-names></name><name><surname>Kaiser</surname><given-names>M</given-names></name><name><surname>Matkowski</surname><given-names>A</given-names></name><name><surname>Hamburger</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>M</given-names></name></person-group><source>Planta Med.</source><year>2011</year><volume>77</volume><fpage>1594</fpage><lpage>1596</lpage><?supplied-pmid 21412700?><pub-id pub-id-type="pmid">21412700</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoet</surname><given-names>S</given-names></name><name><surname>St&#x000e9;vigny</surname><given-names>C</given-names></name><name><surname>H&#x000e9;rent</surname><given-names>MF</given-names></name><name><surname>Quetin-Leclercq</surname><given-names>J</given-names></name></person-group><source>Planta Med.</source><year>2006</year><volume>72</volume><fpage>480</fpage><?supplied-pmid 16557466?><pub-id pub-id-type="pmid">16557466</pub-id></element-citation></ref></ref-list></back></article>